Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Financing Activities (2016 - 2025)

Collegium Pharmaceutical has reported Cash from Financing Activities over the past 10 years, most recently at -$21.8 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$21.8 million for Q4 2025, up 47.14% from a year ago — trailing twelve months through Dec 2025 was -$110.2 million (down 81.91% YoY), and the annual figure for FY2025 was -$110.2 million, down 81.91%.
  • Cash from Financing Activities for Q4 2025 was -$21.8 million at Collegium Pharmaceutical, down from -$14.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for COLL hit a ceiling of $517.8 million in Q1 2022 and a floor of -$114.2 million in Q2 2024.
  • Median Cash from Financing Activities over the past 5 years was -$26.2 million (2021), compared with a mean of $1.8 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 242.64% in 2021 and later skyrocketed 4614.86% in 2022.
  • Collegium Pharmaceutical's Cash from Financing Activities stood at -$42.5 million in 2021, then soared by 39.24% to -$25.8 million in 2022, then tumbled by 162.66% to -$67.8 million in 2023, then skyrocketed by 39.14% to -$41.3 million in 2024, then skyrocketed by 47.14% to -$21.8 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$21.8 million (Q4 2025), -$14.8 million (Q3 2025), and -$48.4 million (Q2 2025) per Business Quant data.